John Crowley
2021
In 2021, John Crowley earned a total compensation of $1.6M as Chief Financial Officer at Fusion Pharmaceuticals, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $159,691 |
|---|---|
| Option Awards | $979,441 |
| Salary | $440,713 |
| Other | $46,266 |
| Total | $1,626,112 |
Crowley received $979.4K in option awards, accounting for 60% of the total pay in 2021.
Crowley also received $159.7K in non-equity incentive plan, $440.7K in salary and $46.3K in other compensation.
Rankings
In 2021, John Crowley's compensation ranked 6,901st out of 12,406 executives tracked by ExecPay. In other words, Crowley earned more than 44.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,901 out of 12,406 | 44th |
Division Manufacturing | 3,011 out of 5,494 | 45th |
Major group Chemicals And Allied Products | 1,334 out of 2,369 | 44th |
Industry group Drugs | 1,190 out of 2,090 | 43rd |
Industry Biological Products, Except Diagnostic Substances | 283 out of 452 | 37th |
Source: SEC filing on April 29, 2022.
Crowley's colleagues
We found two more compensation records of executives who worked with John Crowley at Fusion Pharmaceuticals in 2021.